期刊文献+

他汀类药物的不良反应分析 被引量:2

Adverse reactions analysis of statins
下载PDF
导出
摘要 目的对他汀类药物的不良反应进行分析,为临床合理用药提供依据。方法对重庆三峡中心医院2010年3月至2012年3月住院服用他汀类药物出现不良反应的85例患者的临床资料进行分析,对不良反应发生时间、他汀类药物分布、不良反应表现等进行统计。结果85例患者中60周岁以上患者有72例,占84.7%;74例患者的不良反应于服用他汀类药物1个月内发生,占87.1%;单独用药25例,联合用药60例;他汀类药物用药中以辛伐他汀为主,共55例,占64.7%;不良反应表现主要包括肌肉毒性54例、肝。肾毒性23例、胃肠道反应17例和神经系统症状15例。结论他汀类药物会产生一定的不良反应,且以肌肉毒性为主,对他汀类药物的使用需慎重,密切关注病情,及时采取应对措施。 Objective To analyze the adverse reactions of statins drug to provide a basis for clinical rational drug use. Methods The clinical data for adverse reactions of eighty-five cases of patients taking statins drug were analyzed. The adverse reactions, statins distribution and adverse reactions performance were analyzed. Results Totally 72 cases of patients were elder than 60 years old, accounting for 84.7% ; adverse reactions of 74 patients on statin drugs occurred within a month, accounting for 87.1% ; Statin medication were mainly simvastatin, accounting for 64.7%. The main side effects included 54 cases of muscle toxicity, 23 cases of liver and kidney toxicity, 17 cases of gastrointestinal reactions and 15 cases of neurological symptoms. Conclusion Statins may cause some adverse reactions including muscle toxicity. The statins should be used carefully.
作者 汪华蓉
出处 《中国医药》 2013年第12期1790-1791,共2页 China Medicine
关键词 他汀类药物 不良反应 Statins Adverse reactions
  • 相关文献

参考文献13

二级参考文献165

共引文献189

同被引文献29

  • 1Chain S, Evans MA, Denenberg JO, et al. Statin-associated muscle-re-lated adverse effects: a case series of 354 patients [J]. Pharmacotherapy ,2010,30 ( 6 ) : 541-553.
  • 2Marie I, Delafenetre H, Massy N, et al. Tendinous disorders at- tributed to statins:a study on ninety-six spontaneous reports in the period 1990-2005 and review of the literature[ J]. Arthritis Rheum,2008,59(3) :367-372.
  • 3http ://liangyi88. com/newsdhtml/1603, html.
  • 4Mullen PJ, Lioscher B, Schamagl H, et al. Effect of simvastatin on cholesterol metabolism in C2C12 myotubes and HepG2 cells,and consequences for statin-incluced myopathy[ J ]. Bio- chem Pharmacol,2010,79 (8) : 1200-1209.
  • 5Ghatak A,Faheem O, Thompson PD. The genetics of statin in- duced myopathy [J]. Athe-rosclerosis,2010,210(2) :337-343.
  • 6Garcia Rodrfguez LA, Herings R, Johansson S. Use of multiple international healthcare databases for the detection of rare drug- associated outcomes: a pharmacoepidemiological programme comparing rosuvastatin with other marketed statins [ J ]. Phar- macoepidemiol Drug Saf,2010,19(12) :1218-1224.
  • 7Nakamura H, Arakawa K, Itakura H, et al. Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study) :a prospective randomized controlled trial [ J ]. Lancet, 2006,368(9542) :1155-1163.
  • 8苏克江,张伟.他汀性肌病:临床实践中不容忽视的问题[J].中华脑血管病杂志(电子版),2008,2(3):168-173. 被引量:14
  • 9温晓娜.他汀类药物的不良反应[J].药学服务与研究,2010,10(5):357-360. 被引量:22
  • 10邹德玲,陈艳丽,赵玫,史瑾,李红,马淑梅.他汀类药物相关肌病的临床特点分析[J].实用药物与临床,2010,13(6):407-409. 被引量:14

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部